Abstract CT055: Phase 1/2 Primary Analysis of ZUMA-6: Axicabtagene Ciloleucel (Axi-Cel) in Combination with Atezolizumab (atezo) for the Treatment of Patients (pts) with Refractory Diffuse Large B Cell Lymphoma (DLBCL)
Cancer research（2020）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要